Creathor Venture related stories
All articles and analysis
CEVEC Pharmaceuticals Raises $8.6MCEVEC Pharmaceuticals, a maker of technology used for the manufacture of complex biologics and therapeutic antibodies, has inked $8.6 million in financing from NRW.BANK, Creathor Venture Fonds, and other undisclosed investors. The money will help with continued development. CEVEC is based in Cologne, Germany.
- European News Briefs, June 2011
BASF buys filtration company from consortium of VCs; Creathor Venture has taken another bite out of German website stylefruits
- Caprotec Adds $1.4M in Series B
Caprotec Bioanalytics GmbH, a Berlin-based biopharmaceutical company, has added $1.4 million in a second tranche of its Series B round, bringing the total raised in the round to $7.2 million. LBBW Venture Capital , Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and other undisclosed investors contributed to the round. Caprotec is based in Berlin, with operations in Burlington, Mass.
- European News Briefs, March 2011
Lovefilm produces payday for Balderton, DFJ Esprit and Index; Orange has an appeal for Dailymotion
- Caprotec Bioanalytics Raises €4 Nillion
Caprotec Bioanalytics, a Berlin, Germany-based developer of capture compound mass spectrometry technology, has raised €4 million in Series B funding. Return backers include Creathor Venture, IBB Beteiligungsgesellschaft and ERP Startfonds.
- peHUB Wire: Monday, May 17, 2010
Random Ramblings
- peHUB Wire: Monday, May 17, 2010
Random Ramblings
- Cevec Pharma Raises €4 Million
CEVEC Pharmaceuticals GmbH, a German developer of a technology platform for developing therapeutic proteins, has raised €4 million. Creathor Venture Fonds and NRW.BANK co-led the round, and were joined by return backers like Sparkasse KoelnBonn and ERP Startfonds.
- HeidelbergCapital ups Accovion stake
Life sciences software business taken over by secondary firm
- Diva AG Raises VC Funding
Diva AG, a Zurich-based developer of a B2B publishing platform for digital media assets, has raised an undisclosed amount of VC funding from Creathor Venture.